Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback